These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 14993408)

  • 41. Wisdom of the crowd.
    Nature; 2005 Nov; 438(7066):281. PubMed ID: 16292279
    [No Abstract]   [Full Text] [Related]  

  • 42. The marketing of osteoporosis.
    Napoli M
    Am J Nurs; 2009 Apr; 109(4):58-61. PubMed ID: 19325320
    [No Abstract]   [Full Text] [Related]  

  • 43. Marketing and branding.
    Pinkerton S
    Nurs Econ; 2002; 20(1):42-3. PubMed ID: 11892549
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of premenstrual syndrome with fluoxetine: an open study.
    Brandenburg S; Tuynman-Qua H; Verheij R; Pepplinkhuizen L
    Int Clin Psychopharmacol; 1993; 8(4):315-7. PubMed ID: 8277154
    [No Abstract]   [Full Text] [Related]  

  • 45. What does the fact of advertising convey to patients?
    Adamjee A; Alfi D; Agarwal D; Braithwaite Y; Chan J; Chey M; Cho H; Choi C
    J Am Coll Dent; 2005; 72(3):22-3. PubMed ID: 16623135
    [No Abstract]   [Full Text] [Related]  

  • 46. Marketing drugs: debating the real cost. Concern about close ties between doctors and pharmaceutical firms are prompting new financial disclosure laws and education efforts.
    Brand R
    State Legis; 2008 Sep; 34(8):26-9. PubMed ID: 18754159
    [No Abstract]   [Full Text] [Related]  

  • 47. Informational content of official pharmaceutical industry web sites about treatments for erectile dysfunction.
    Waack KE; Ernst ME; Graber MA
    Ann Pharmacother; 2004 Dec; 38(12):2029-34. PubMed ID: 15507499
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Direct-to-consumer advertising of psychotropics. An emerging and evolving form of pharmaceutical company influence.
    Gilbody S; Wilson P; Watt I
    Br J Psychiatry; 2004 Jul; 185():1-2. PubMed ID: 15231547
    [No Abstract]   [Full Text] [Related]  

  • 49. Open letter (and invitation) to the pharmaceutical industry: "no, we cannot just present your slide deck …".
    Benbadis SR; Faught RE; Hirsch L; Sperling M; Slater J; Sirven J
    Epilepsy Behav; 2010 Nov; 19(3):544-5. PubMed ID: 20833110
    [No Abstract]   [Full Text] [Related]  

  • 50. A change in the market--investing in diagnostics.
    Batchelder K; Miller P
    Nat Biotechnol; 2006 Aug; 24(8):922-6. PubMed ID: 16900131
    [No Abstract]   [Full Text] [Related]  

  • 51. Australian consumer responses to DTCA and other pharmaceutical company sponsored advertisements.
    Hall DV; Jones SC
    Aust N Z J Public Health; 2008 Oct; 32(5):471-8. PubMed ID: 18959553
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Case history: the discovery of fluoxetine hydrochloride (Prozac).
    Wong DT; Perry KW; Bymaster FP
    Nat Rev Drug Discov; 2005 Sep; 4(9):764-74. PubMed ID: 16121130
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recombinant protein therapeutics--success rates, market trends and values to 2010.
    Pavlou AK; Reichert JM
    Nat Biotechnol; 2004 Dec; 22(12):1513-9. PubMed ID: 15583654
    [No Abstract]   [Full Text] [Related]  

  • 54. My stand against DTC ads.
    Bellard BM
    Med Econ; 2004 Feb; 81(4):104. PubMed ID: 15015419
    [No Abstract]   [Full Text] [Related]  

  • 55. "But doctors do it...": nurses' views of gifts and information from the pharmaceutical industry.
    Jutel A; Menkes DB
    Ann Pharmacother; 2009 Jun; 43(6):1057-63. PubMed ID: 19470854
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The creation of the medical consumer.
    Berg TL
    S D Med; 2008 Feb; 61(2):42. PubMed ID: 18432148
    [No Abstract]   [Full Text] [Related]  

  • 57. Legal cannabis industry adopting strategies of the tobacco industry.
    Subritzky T; Lenton S; Pettigrew S
    Drug Alcohol Rev; 2016 Sep; 35(5):511-3. PubMed ID: 27650812
    [No Abstract]   [Full Text] [Related]  

  • 58. Generics market in Greece: the pharmaceutical industry's beliefs.
    Geitona M; Zavras D; Hatzikou M; Kyriopoulos J
    Health Policy; 2006 Nov; 79(1):35-48. PubMed ID: 16386326
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Incomplete syllogisms as techniques of medicalization: The case of direct-to-consumer advertising in popular magazines, 1997 to 2003.
    Arney J; Rafalovich A
    Qual Health Res; 2007 Jan; 17(1):49-60. PubMed ID: 17170243
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [A proposal for the prevention of ethical problems related to drug promotion: a national network for drug information].
    Civaner M
    Turk Psikiyatri Derg; 2008; 19(3):310-7. PubMed ID: 18791884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.